Proscia, Ibex, and Quest Diagnostics Webinar: Quantifying the Value of AI-Powered Digital WorkflowsSIGN UP

Q/A: Proscia Co-Founder Talks Impact of DICOM in Digital Pathology

Proscia
By Author Proscia | November 7, 2024

In this Q&A, Nathan Buchbinder, our Chief Strategy Officer, delves into the impact of DICOM on the pathology industry. He explores the key benefits of this standardization, its implications for AI development, and how it paves the way for a more integrated and innovative future in pathology.

Read Full Article

Our website uses cookies. By using this site, you agree to its use of cookies.

Agree

Privacy Policy